Giulio Cossu is now group leader of Cell therapy for myopathies Unit at IRCCS Ospedale San Raffaele, Professor of Regenerative Medicine at the University of Manchester and visiting Professor at the Max Delbruck-Charitè Centre in Berlin. He received his MD degree from the University of Rome (Italy) in 1977. Cossu was appointed director of the Stem Cell Research Institute of the IRCCS Ospedale San Raffaele in Milan in 2000 and he was appointed Director of the San Raffaele Division of Regenerative Medicine at the same institute in 2008, while in the same period (2005) he became professor of Histology at the University of Milan. From 2003 to 2006, he was also appointed Scientific Director of the San Raffaele Biomedical Science Park of Rome. In 2013 he became Professor of Human Stem Cell Biology at UCL and in 2013 he moved to his actual position in Manchester.

Prof. Cossu is member of various scientific societies. He is member of the CSS (Consiglio Superiore di Sanità), of the scientific advisory board of Biomedicine in Basel and of CNR. He is fellow of the Accademia dei Lincei and of the Academy of Medical Sciences. He is also member of the Committee for Advanced therapies at EMA, chair&member of Panlel LS7 (ERC) and member of the European Academy of Sciences. Cossu is Senior Editor of EMBO Molecular Medicine, also che EMBO Member.

Prof. Cossu is internationally recognized for his pioneering work on skeletal myogenesis and for having developed the first cell therapy protocol with stem cells for muscular dystrophy. He is author of 250 peer-reviewed articles (H index: 73). He has been recipient of several international grants (>10 M€ ) from Wellcome Trust, BHF, MRC, ERC, EC, MDA, AFM, DPP.